Latest Aetna Update- April 2025 Source Aetna No Longer Requiring Precertification (Effective March 1, 2025) BRCA Genetic Testing (CPT Code 81433) Evrysdi (risdiplam) J8499 Require Precertification Effective March 14, 2025 Ziihera (zanidatamab-hrii, J3490, J3590, C9399, J9999) Bizengri (zenocutuzumab-zbco, J3490, J3590, C9399, J9999) Unloxcyt (cosibelimab-ipdl, J3490, J3590, C9399, J9999) Effective April 1, 2025 Opdivo Qvantig (nivolumab and hyaluronidase-nvhy) J3490, J3590, C9399, J9999 Medicare only: Axtle (pemetrexed, avyxa) J9292 Pemrydi RTU (pemetrexed) J9324 Effective April 4, 2025 Jubbonti (denosumab-bbdz) J3490, J3590, C9399 Wyost (denosumab-bbdz) J3490, J3590, C9399 Effective April 18, 2025 Datroway (datopotamab deruxtecan-dlnk, J3490, J3590, C9399, J9999) precertification includes site of care Ryoncil (remestemcel-L, J3490, J3590, C9399, J9999) Submitting Precertification Requests Submit requests at least 2 weeks in advance , including the actual date of service

Your provider will design a personalized plan for you.
Remember, this is a marathon, not a sprint
Sporadic use or failure to implement supporting lifestyle changes significantly reduces the supplement's effectiveness and value proposition
If ketoacidosis is suspected, discontinue XIGDUO XR, promptly evaluate, and treat ketoacidosis, if confirmed